Filter
2610
Filtered Results: 2610
Text search:
TB
Treatment
outcomes
Featured
Recommendations
251
New Publications
752
Language
Document type
No document type
1702
Studies & Reports
373
Guidelines
281
Manuals
81
Strategic & Response Plan
78
Fact sheets
29
Training Material
28
Situation Updates
23
Infographics
8
Resource Platforms
5
Online Courses
1
Videos
1
Countries / Regions
India
130
Kenya
99
South Africa
96
Global
84
Western and Central Europe
67
Ethiopia
66
Tanzania
63
Uganda
57
Namibia
56
Malawi
55
Zambia
55
Nepal
50
Sierra Leone
45
Nigeria
43
Africa
43
Eastern Europe
42
Liberia
39
Myanmar / Burma
39
Bangladesh
37
Ghana
36
Rwanda
36
Lesotho
34
Ukraine
25
Cambodia
24
Latin America and the Carribbean
23
Zimbabwe
20
Asia
20
Philippines
19
South–East Asia Region
17
Botswana
17
Russia
16
Mozambique
15
Indonesia
14
East and Southern Africa
12
Syria
9
Senegal
9
Germany
9
Pakistan
9
Colombia
8
Albania
8
South Sudan
8
Eswatini/ Swaziland
8
West and Central Africa
7
Brazil
7
Georgia
7
Burkina Faso
6
Haiti
6
Congo, Democratic Republic of
6
Tajikistan
5
Benin
5
Argentina
5
Thailand
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Southern Africa
4
Lebanon
4
Sudan
4
Timor Leste/ East Timor
3
El Salvador
3
Iran
3
Laos
3
Estonia
3
Afghanistan
3
Guinea
3
Armenia
3
USA
3
Jordan
3
Western Pacific Region
3
Paraguay
3
North America
3
Vietnam
3
Yemen
3
Angola
3
Somalia
3
Cameroon
2
Peru
2
Saudi Arabia
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Sri Lanka
2
Iraq
2
North Macedonia
1
Gambia
1
Kazakhstan
1
Chile
1
Singapore
1
Morocco
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Guinea-Bissau
1
Venezuela
1
Ireland
1
Uruguay
1
Turkmenistan
1
Maldives
1
Tunisia
1
Azerbaijan
1
Belarus
1
Belize
1
Costa Rica
1
Panama
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Central African Republic
1
Honduras
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1141
Clinical Guidelines
212
Public Health
109
Women & Child Health
78
Key Resources
59
Capacity Building
38
Pharmacy & Technologies
20
Toolboxes
TB
529
HIV
385
AMR
83
Mental Health
76
COVID-19
69
NTDs
64
Caregiver
56
NCDs
47
Pharmacy
40
Global Health Education
34
Ebola & Marburg
29
Disability
24
Health Financing Toolbox
22
Refugee
21
Conflict
21
Rapid Response
20
Polio
19
Planetary Health
16
Malaria
16
Natural Hazards
8
Cholera
5
Social Ethics
4
Zika
4
Specific Hazards
2
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation...
HIV Treatment
Policy Brief
July 2017
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
Namibia is estimated to be at 94-97-93 as defined by the UNAIDS 95-95-95 treatment cascade, one of the first high burden countries to approach epidemic control. COP22 is about sustaining the impact of years of investment and partnership with the Namibian government and other stakeholders by employin...
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
PLoS ONE 15(1): e0228135.
The introduction of “Treat All” (TA) has been promoted to increase the effectiveness of HIV/AIDS treatment by having patients initiate antiretroviral therapy at an earlier stage of their illness. The impact of introducing TA on the unit cost of treatment has been less ...
HIV/TB Research Meeting; March 3, 2013
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Stop TB Communicable Diseases
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal...
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
One key aim of tuberculosis (TB) prevention and care is to render them more people-centred, which means further boosting and improving ambulatory care models across the countries of Eastern Europe and central Asia. This note is intended to remind interested parties of the evidence that shows that am...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
